Articles

Senate looks to cut $1 trillion from Medicaid. Here’s who would be hurt most.

Senate Republicans have unveiled a sweeping plan to overhaul the Medicaid program, with changes policy analysts warn could lead to even greater coverage losses and pain for hospital systems than the aggressive proposal passed by the House of Representatives last month.

Nvidia could become a nearly $5 trillion company. Here’s how.

Barclays analysts raised their price target to $200, highlighting greater optimism about Blackwell and the company’s earnings potential.

Solar stocks plunge on Senate bill’s tax-credit phase-out, but analysts say investors should be happy

S&P components Enphase Energy and First Solar move lower by double-digit percentages.

Is the stock market open on Juneteenth? Will the post office deliver mail?

Here’s what is closed on Juneteenth this Thursday, June 19, to observe the newest federal holiday.

Lennar sees home prices drop to 5-year lows, but they’re still too high

Lennar sees the average price of homes delivered for the current quarter falling to the lowest levels seen in eight years.

Industrial output fell in May — a sign of growing weakness in the factory sector

Trump tariffs are not boosting domestic manufacturers.

Here’s what the Fed’s former No. 2 says about tariffs, the bond market — and 3% inflation

Tariffs aren’t yet showing up in inflation data, but that doesn’t mean they won’t in the coming months, says Richard Clarida, a former Federal Reserve Vice Chair and now an economic adviser at Pimco

Home builders lose confidence, resort to price cuts as buyers steer clear of housing market

Builders’ confidence in the housing market sank in June, the National Association of Home Builders said.

Shoppers cut spending at retailers in May. Trade wars still a drag on the economy.

Simmering trade wars have created a sort of stop-and-start economy — and the latest snapshot of retail sales in May underscores the threat to U.S. growth.

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.

U.S. Treasurys may be losing their safe-haven status — and these bonds could take their place

After Israel attacked Iran on June 13, U.S. Treasury yields rose while other countries’ bond yields declined.

Trump’s next Fed picks will be a dramatic showdown — with your mortgage payment and retirement savings on the line

Trump is testing how far he can push the Fed without breaking it. Why you should care about his choices.
1 368 369 370 371 372 2,495